Latest News

Pediatric epilepsy surgery may improve cognition and behavior


 

REPORTING FROM CNS 2019

After a child undergoes epilepsy surgery, families may perceive a sustained improvement in the child’s behavior and cognition, regardless of whether the child is seizure-free, according to a study presented at the annual meeting of the Child Neurology Society. The presence of comorbidities such as mood disorders and autism may influence the likelihood of perceived improvement, whereas the type of surgery may not.

Trishna Kantamneni, MD, director of pediatric epilepsy at UC Davis in Sacremento

Dr. Trishna Kantamneni

“The parents and the families of the patients perceive that, even if the patients are not completely seizure free, the behavior and cognitive outcomes are better if there is some sort of seizure improvement,” said Trishna Kantamneni, MD, director of pediatric epilepsy at UC Davis in Sacramento.

To assess behavioral and cognitive outcomes following pediatric epilepsy surgery and to identify factors that predict improvement, Dr. Kantamneni and colleagues at the Cleveland Clinic Epilepsy Center retrospectively reviewed 126 patients younger than 18 years who underwent epilepsy surgery for medically refractory epilepsy during 2009-2016.

The primary outcome measure was the Impact of Childhood Neurologic Disability Scale (ICNDS), a parent-reported scale that assesses the behavior, cognition, and physical or neurologic disability of children with epilepsy. Parents completed the ICNDS preoperatively and at 6, 12, and 24 months after surgery. The researchers constructed separate linear mixed effects models to identify predictors of postoperative changes in ICNDS score.

Of the 126 patients, 62.7% were male, the median duration of epilepsy was 4.7 years, and 69.8% were seizure-free at the 2-year follow-up. Postoperative ICNDS scores were available for 103 patients at 6 months and for 54 patients at 24 months.

Before surgery, the average total ICNDS score was 55.7. At 6 months after surgery, the average score was 34.6, and at 24 months, it was 32.1, representing significant improvement from baseline.

In addition, behavior, cognition, and epilepsy subscores also improved post operatively, and the improvement persisted through 24 months. ICNDS scores significantly improved “even in patients who were not seizure-free after surgery,” by an average of about 22 points, the researchers said.

The absence of comorbid autism, cognitive impairment, and global developmental impairment and the absence of anxiety, depression, and ADHD were predictors of improved total ICNDS scores. Tumor pathology and being seizure free at 2 years also predicted improved scores. Duration and type of epilepsy, the number of antiepileptic drugs that patients were taking before surgery, and lobe of surgery were not predictive of improved ICNDS scores.

Dr. Kantamneni had no relevant disclosures.

SOURCE: Kantamneni T et al. CNS 2019, Abstract 51.

Recommended Reading

Mortality is high in pediatric superrefractory status epilepticus
Journal of Clinical Outcomes Management
ECT breaks super-refractory status epilepticus
Journal of Clinical Outcomes Management
Ketogenic diets are what’s cooking for drug-refractory epilepsy
Journal of Clinical Outcomes Management
‘Pot’ is still hot for Dravet, Lennox-Gastaut
Journal of Clinical Outcomes Management
A practical tool predicts childhood epilepsy diagnosis
Journal of Clinical Outcomes Management
Intranasal midazolam as first line for status epilepticus
Journal of Clinical Outcomes Management
Combo therapy outcomes for West syndrome prove no better than monotherapy
Journal of Clinical Outcomes Management
CBD: What physicians need to know about it
Journal of Clinical Outcomes Management
Does AED prophylaxis delay seizure onset in children with brain tumors?
Journal of Clinical Outcomes Management
Delay in EEG monitoring associated with increased seizure duration in pediatric refractory status epilepticus
Journal of Clinical Outcomes Management